Page 81 - GUIAS ESC ESH 2018

ESC/ESH Guidelines 81

.
Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey . . Task Force for the Management of Arterial Hypertension of the European
GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, . . Society of Hypertension (ESH) and of the European Society of Cardiology
Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw . . . (ESC). J Hypertens 2007;25:1105–1187.
A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, . . 17. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T,
Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney . . Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T,
M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, . . . Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM,
Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, . . Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J,
Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, . . Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E,
Yonemoto N, Zaki ME, Murray CJ. Global burden of hypertension and systolic . . Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P,
blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA . . . Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C,
2017;317:165–182. . . Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P,
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of . . Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes
usual blood pressure to vascular mortality: a meta-analysis of individual data for . . . PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL,
one million adults in 61 prospective studies. Lancet 2002;360:1903–1913. . . Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD,
5. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 . . Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA,
to 2015: a pooled analysis of 1479 population-based measurement studies with . . Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H,
19.1 million participants. Lancet 2017;389:37–55. . . Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH,
6. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, . . . Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryden L, Sirenko
Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, . . Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C,
McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum . . Volpe M, Wood DA. 2013 ESH/ESC guidelines for the management of arterial
A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, . . . hypertension: the Task Force for the Management of Arterial Hypertension of
Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, . . the European Society of Hypertension (ESH) and of the European Society of
Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al . . Cardiology (ESC). Eur Heart J 2013;34:2159–2219.
Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S, INTERSTROKE . . 18. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti
Investigators. Global and regional effects of potentially modifiable risk factors . . . C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha
associated with acute stroke in 32 countries (INTERSTROKE): a case-control . . M, Stabouli S, Webb NJ, Wuhl E, Zanchetti A. 2016 European Society of
study. Lancet 2016;388:761–775. . . Hypertension guidelines for the management of high blood pressure in children
7. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, . . . and adolescents. J Hypertens 2016;34:1887–1920.
White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, . . 19. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J.
Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: . . Global burden of hypertension: analysis of worldwide data. Lancet
lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million . . 2005;365:217–223.
people. Lancet 2014;383:1899–1911. . . . 20. Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, Oto A, Potpara
8. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on . . TS, Steffel J, Marin F, de Oliveira Figueiredo MJ, de Simone G, Tzou WS, En
outcome incidence in hypertension. 1. Overview, meta-analyses, and meta- . . Chiang C, Williams B. Hypertension and cardiac arrhythmias: executive summary
regression analyses of randomized trials. J Hypertens 2014;32:2285–2295. . . . of a consensus document from the European Heart Rhythm Association (EHRA)
9. Tsai WC, Wu HY, Peng YS, Yang JY, Chen HY, Chiu YL, Hsu SP, Ko MJ, Pai MF, . . and ESC Council on Hypertension, endorsed by the Heart Rhythm Society
Tu YK, Hung KY, Chien KL. Association of intensive blood pressure control and . . (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad
kidney disease progression in nondiabetic patients with chronic kidney disease: a . . Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE). Eur
systematic review and meta-analysis. JAMA Intern Med 2017;177:792–799. . . . Heart J Cardiovasc Pharmacother 2017;3:235–250.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj . . 21. Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA,
A, Pais P, Varigos J, Lisheng L, INTERHEART Study Investigators. Effect of poten- . . McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck
tially modifiable risk factors associated with myocardial infarction in 52 countries . . . LM, Knopman DS. Associations between midlife vascular risk factors and 25-year
(the INTERHEART study): case-control study. Lancet 2004;364:937–952. . . incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort.
11. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, . . JAMA Neurol 2017;74:1246–1254.
Masso-Gonzalez EL, Jimenez FJ, Perk J, Steg PG, De Backer G, Rodriguez- . . 22. Rovio SP, Pahkala K, Nevalainen J, Juonala M, Salo P, Kahonen M, Hutri-Kahonen
Artalejo F. Achievement of treatment goals for primary prevention of cardiovas- . . . N, Lehtimaki T, Jokinen E, Laitinen T, Taittonen L, Tossavainen P, Viikari JSA,
cular disease in clinical practice across Europe: the EURIKA study. Eur Heart J . . Rinne JO, Raitakari OT. Cardiovascular risk factors from childhood and midlife
2011;32:2143–2152. . . cognitive performance: the Young Finns study. J Am Coll Cardiol
12. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, . . 2017;69:2279–2289.
Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, . . . 23. Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jorgensen T, Broda
Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz . . G, Palmieri L, Giampaoli S, Donfrancesco C, Kee F, Mancia G, Cesana G,
A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S, PURE Study . . Kuulasmaa K, Sans S, Olsen MH, MORGAM Project. Impact of age on the impor-
Investigators. Prevalence, awareness, treatment, and control of hypertension in . . tance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk,
rural and urban communities in high-, middle-, and low-income countries. JAMA . . . Genetics, Archiving, and Monograph (MORGAM) project. Hypertension
2013;310:959–968. . . 2012;60:1117–1123.
13. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in . . 24. Brown DW, Giles WH, Greenlund KJ. Blood pressure parameters and risk of
England: a serial cross-sectional study from 1994 to 2011. Lancet . . . fatal stroke, NHANES II mortality study. Am J Hypertens 2007;20:338–341.
2014;383:1912–1919. . . 25. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S,
14. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, Mancia G, . . Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular dis-
Morganti A, Pontremoli R, Trimarco B, Zanchetti A, Volpe M. Blood pressure . . ease in the Asia Pacific region. J Hypertens 2003;21:707–716.
control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. . . . 26. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in
J Hypertens 2012;30:1065–1074. . . predicting risk for coronary heart disease? The Framingham heart study.
15. European Society of Hypertension-European Society of Cardiology Guidelines . . Circulation 1999;100:354–360.
Committee. 2003 European Society of Hypertension-European Society of . . . 27. Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet
Cardiology guidelines for the management of arterial hypertension. J Hypertens . . 2008;371:2219–2221.
2003;21:1011–1053. . . 28. Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R,
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi . . Cohen J, Stamler J, MRFIT Research Group. Pulse pressure and cardiovascular
G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, . . . disease-related mortality: follow-up study of the Multiple Risk Factor
Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, . . Intervention Trial (MRFIT). JAMA 2002;287:2677–2683.
Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen . . 29. Franklin SS, Lopez VA, Wong ND, Mitchell GF, Larson MG, Vasan RS, Levy D.
SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, . . Single versus combined blood pressure components and risk for cardiovascular
Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, . . . disease: the Framingham Heart Study. Circulation 2009;119:243–250.
Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine . . 30. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS,
S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O’Brien E, . . Richard AJ, Rother J, Wilson PW, REACH Registry Investigators. International
Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, . . . prevalence, recognition, and treatment of cardiovascular risk factors in outpa-
Williams B. 2007 Guidelines for the management of arterial hypertension: the . tients with atherothrombosis. JAMA 2006;295:180–189.

Downloaded from https://academic.oup.com/eurheartj/advance-article-abstract/doi/10.1093/eurheartj/ehy339/5079119
by guest
on 27 August 2018